Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -9.397\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CCOC(=O)c1sc2nc3n(c(=O)c2c1C)CCC(C)CC3
b) CCCc1nnc(NC(=O)c2c(O)c3cccc4c3n(c2=O)CCC4)s1
c) CCCC(=O)n1nc(-c2ccco2)nc1N
d) CC(=O)Nc1ccc(NC(=O)CCOc2cc(C)ccc2C)cc1
Answer: b. CCCc1nnc(NC(=O)c2c(O)c3cccc4c3n(c2=O)CCC4)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1nnc(NC(=O)c2c(O)c3cccc4c3n(c2=O)CCC4)s1
CCCc1nnc(NC(=O)c2c(O)c3cccc4c3n(c2=O)CCC4)s1
4-hydroxy-2-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)-1-azatricyclo[7.3.1.05,13]trideca-3,5,7,9(13)-tetraene-3-carboxamide